Keywords: approvals, lovenox, angina, rhone-poulenc, rorer, received, marketing
More Approvals For Lovenox In Angina
Article | 14 January 1998
Rhone-Poulenc Rorer has received marketing clearance in 11 morecountries for Clexane/Lovenox (enoxaparin) in a new indication, the treatment of unstable ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
